loading

Pacira Biosciences Inc Azioni (PCRX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
9.67%
196.87
179.52 181.10 168.92 168.57
Cost Of Revenue
17.57%
40.30
34.28 40.87 34.31 38.86
Gross Profit
7.81%
156.57
145.24 140.23 134.62 129.71
Operating Expenses
11.06%
154.23
138.88 131.73 132.63 269.24
Benefits Costs and Expenses
15.48%
196.30
169.99 183.03 160.22 307.43
Costs And Expenses
12.35%
194.53
173.15 172.60 166.93 308.10
Operating Income/Loss
63.22%
2.34
6.362 8.499 1.99 -139.53
Nonoperating Income/Loss
155.95%
-1.769
3.162 -10.43 6.716 0.671
Income/Loss From Continuing Operations Before Tax
94.00%
0.571
9.524 -1.927 8.706 -138.86
Income Tax Expense/Benefit, Deferred
146.38%
-3.744
8.072 0.752 1.397 1.115
Income Tax Expense/Benefit
126.05%
-1.066
4.092 2.92 3.894 4.61
Income/Loss From Continuing Operations After Tax
69.86%
1.637
5.432 -4.847 4.812 -143.47
Net Income/Loss
69.86%
1.637
5.432 -4.847 4.812 -143.47
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
101.57%
-0.691
44.04 45.46 46.27 46.13
Diluted Average Shares
101.55%
-0.687
44.46 45.46 46.53 46.13
Basic Earnings Per Share
66.67%
0.04
0.12 -0.11 0.10 -3.11
Diluted Earnings Per Share
66.67%
0.04
0.12 -0.11 0.10 -3.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$22.94
price up icon 1.15%
drug_manufacturers_specialty_generic RGC
$23.23
price down icon 3.21%
drug_manufacturers_specialty_generic RDY
$14.13
price down icon 1.53%
$129.78
price up icon 1.57%
$13.51
price down icon 2.10%
$536.12
price up icon 0.62%
Capitalizzazione:     |  Volume (24 ore):